A COMPOSITION COMPRISING THE COMPOUND ISOLATED FROM CHRYSANTHEMUM INDICUM FOR TREATING OR PREVENTING CEREBROVASCULAR SYSTEM INVOLVED ANXIETY AND THE USE THEREOF
The present invention relates to a composition comprising acacetin-7-O-glucuronide or luteolin-7-O-glucuronide isolated from an extract of Chrysanthemum indicum showing tranquilizing activity to treat and prevent cerebrovascular system involved anxiety. The inventive compounds showed potent increasi...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
03.10.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to a composition comprising acacetin-7-O-glucuronide or luteolin-7-O-glucuronide isolated from an extract of Chrysanthemum indicum showing tranquilizing activity to treat and prevent cerebrovascular system involved anxiety. The inventive compounds showed potent increasing effect on the time spent in open arm or closed arm and the number of open arm entries in elevated plus-maze test. Therefore it can be used as the therapeutics or health food for treating or preventing cerebrovascular system involved anxiety with safe.
La présente invention concerne une composition comprenant de l'acacétin-7-O-glucuronide ou du lutéolin-7-O-glucuronide isolés à partir d'un extrait de Chrysanthemum indicum montrant une activité tranquillisante, pour traiter et prévenir l'anxiété impliquée par le système cérébrovasculaire. Les composés de l'invention ont montré un fort effet d'augmentation dans le temps passé dans le bras ouvert ou le bras fermé, et du nombre d'entrées dans le bras ouvert dans un test de labyrinthe surélevé. Par conséquent, ladite composition peut être utilisée comme produit thérapeutique ou aliment fonctionnel pour le traitement ou la prévention de l'anxiété impliquée par le système cérébrovasculaire de manière sûre. |
---|---|
AbstractList | The present invention relates to a composition comprising acacetin-7-O-glucuronide or luteolin-7-O-glucuronide isolated from an extract of Chrysanthemum indicum showing tranquilizing activity to treat and prevent cerebrovascular system involved anxiety. The inventive compounds showed potent increasing effect on the time spent in open arm or closed arm and the number of open arm entries in elevated plus-maze test. Therefore it can be used as the therapeutics or health food for treating or preventing cerebrovascular system involved anxiety with safe.
La présente invention concerne une composition comprenant de l'acacétin-7-O-glucuronide ou du lutéolin-7-O-glucuronide isolés à partir d'un extrait de Chrysanthemum indicum montrant une activité tranquillisante, pour traiter et prévenir l'anxiété impliquée par le système cérébrovasculaire. Les composés de l'invention ont montré un fort effet d'augmentation dans le temps passé dans le bras ouvert ou le bras fermé, et du nombre d'entrées dans le bras ouvert dans un test de labyrinthe surélevé. Par conséquent, ladite composition peut être utilisée comme produit thérapeutique ou aliment fonctionnel pour le traitement ou la prévention de l'anxiété impliquée par le système cérébrovasculaire de manière sûre. |
Author | CHOI, SOO-MI KWON, JAE-WON CHOI, SEUNG-MIN KIM, JAE-YOON CHOI, JONG-GIL LEE, JIN-WOO |
Author_xml | – fullname: CHOI, SEUNG-MIN – fullname: CHOI, JONG-GIL – fullname: LEE, JIN-WOO – fullname: CHOI, SOO-MI – fullname: KIM, JAE-YOON – fullname: KWON, JAE-WON |
BookMark | eNqNjc0OgjAQhDnowb93aOLZRITEeKxlkSbQJduCciLE1JMBEnwgH9WCPoCnbyY7M7v0Zm3X2oX35kxglqOWRqKaNEkt1YWZBL6nQkVMaky5gYjFhBkTCVWaK5fIioxJFUnhGCMxQ8DN2HY6JyhBTU4AwZmw5FoUKSemK21gbJaYlm6Vq5sEUzlG099Cw0gCjNfe_NE8B7v5ceVtYzAi2dm-q-3QN3fb2ld9xcPeD_zwGPon7gf_pT7kxkhs |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSITION COMPRENANT LE COMPOSÉ ISOLÉ DE CHRYSANTHEMUM INDICUM POUR LE TRAITEMENT OU LA PRÉVENTION DE L'ANXIÉTÉ IMPLIQUÉE PAR LE SYSTÈME CÉRÉBROVASCULAIRE ET SON UTILISATION |
ExternalDocumentID | WO2013147419A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2013147419A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:55:57 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2013147419A13 |
Notes | Application Number: WO2013KR01279 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131003&DB=EPODOC&CC=WO&NR=2013147419A1 |
ParticipantIDs | epo_espacenet_WO2013147419A1 |
PublicationCentury | 2000 |
PublicationDate | 20131003 |
PublicationDateYYYYMMDD | 2013-10-03 |
PublicationDate_xml | – month: 10 year: 2013 text: 20131003 day: 03 |
PublicationDecade | 2010 |
PublicationYear | 2013 |
RelatedCompanies | YD LIFE SCIENCE CO., LTD |
RelatedCompanies_xml | – name: YD LIFE SCIENCE CO., LTD |
Score | 2.9064698 |
Snippet | The present invention relates to a composition comprising acacetin-7-O-glucuronide or luteolin-7-O-glucuronide isolated from an extract of Chrysanthemum... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | A COMPOSITION COMPRISING THE COMPOUND ISOLATED FROM CHRYSANTHEMUM INDICUM FOR TREATING OR PREVENTING CEREBROVASCULAR SYSTEM INVOLVED ANXIETY AND THE USE THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131003&DB=EPODOC&locale=&CC=WO&NR=2013147419A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8IwsCFo1DdFjR9ommj2RgQ2YHsgZnSdzLCVdB_CE6EbJCZmEJnx7_hTvRZQnni6a6-9pm2u99EvhB4zqyla-lx-aDJPa4aZ1mvmXK-DIVcHkmk1zFTGO_yg3Y-N11FrVEIf27sw6p3Qb_U4IkhUCvJeqPV6-R_EctTZytWTeIesxbMbdR1t4x03ZLha15xelw6Zw4hGCPhtWsDXNAPUp2WDr3QAhnRHygNNevJeynJXqbin6HAI_PLiDJVmeQUdk-3faxV05G-2vAHdSN_qHP3YmDB_yEJPxpUUzr3QC15w1KdrUhw42AvZwIYFCbuc-Zj0-Ti0Ayjhxz72AscjAMH3wxGndiRrAw4TkdBApQjltMdZYockHtgch-MworJmwgYJcLWDkUejMUBHtRuHVEJOmXuBHlwakX4Nujr5G9nJG9sdF_0SlfNFPrtCWGSpZXUaaUNMM6PVnFq6EMJsplZbTNNpPbtG1X2cbvaTb9GJTKozcXoVlYvPr9kd6PZC3Ksp-QXQzpyq |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFG6IGvFNUeMFtYmGNyIwLtsDMaPr3HRrSXcRnggdkJgYIILx7_hTPS2gPPF0Tve1Z1mb03NZLwg9jKyabBgTdaHJJCvXzaxSNidGBRy5CkCmVTUzle8IWdNL6i-9Ri-HPjZ7YfQ5od_6cETQqAz0fann6_l_EsvRaysXj_IdHs2e3LjtlNbRcVWlq42S02nTLnc4KRECcVuJiRVWB_Np2RAr7YOT3VL6QNOO2pcy3zYq7jE66IK86fIE5cbTAsqTzd1rBXQYrn95A7vWvsUp-rEx4WGXR77KK2le-JHPnnHs0RWUMAf7EQ9smJCwK3iIiSf6kc2gRpiE2GeOT4BC7IdjQe1YtQYeBiKlTJcIFbQjeGpHJAlsgaN-FFPVMuVBClJt1vNp3Afq6PcmEVVUUO6eoXuXxsQrw6cO_np28Ma3-8U4R3vT2XR8gbAcZZbVqmZVORzVG7WhZUgpzVpmNeUwG1ZGl6i4S9LVbvgO5b04DAaBz16v0ZGC9Po4o4j2lp9f4xuw80t5q4fnF1k_n50 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=A+COMPOSITION+COMPRISING+THE+COMPOUND+ISOLATED+FROM+CHRYSANTHEMUM+INDICUM+FOR+TREATING+OR+PREVENTING+CEREBROVASCULAR+SYSTEM+INVOLVED+ANXIETY+AND+THE+USE+THEREOF&rft.inventor=CHOI%2C+SEUNG-MIN&rft.inventor=CHOI%2C+JONG-GIL&rft.inventor=LEE%2C+JIN-WOO&rft.inventor=CHOI%2C+SOO-MI&rft.inventor=KIM%2C+JAE-YOON&rft.inventor=KWON%2C+JAE-WON&rft.date=2013-10-03&rft.externalDBID=A1&rft.externalDocID=WO2013147419A1 |